Ocular indicators of Alzheimer's: exploring disease in the retina

NJ Hart, Y Koronyo, KL Black… - Acta neuropathologica, 2016‏ - Springer
Although historically perceived as a disorder confined to the brain, our understanding of
Alzheimer's disease (AD) has expanded to include extra-cerebral manifestation, with …

Dementia in Latin America: assessing the present and envisioning the future

MA Parra, S Baez, R Allegri, R Nitrini, F Lopera… - Neurology, 2018‏ - neurology.org
The demographic structure of Latin American countries (LAC) is fast approaching that of
develo** countries, and the predicted prevalence of dementia in the former already …

Unfolded protein response IRE1/XBP1 signaling is required for healthy mammalian brain aging

F Cabral‐Miranda, G Tamburini, G Martinez… - The EMBO …, 2022‏ - embopress.org
Aging is a major risk factor to develop neurodegenerative diseases and is associated with
decreased buffering capacity of the proteostasis network. We investigated the significance of …

Amyloid β-protein oligomers and Alzheimer's disease

EY Hayden, DB Teplow - Alzheimer's research & therapy, 2013‏ - Springer
The oligomer cascade hypothesis, which states that oligomers are the initiating pathologic
agents in Alzheimer's disease, has all but supplanted the amyloid cascade hypothesis …

Alzheimer's retinopathy: seeing disease in the eyes

N Mirzaei, H Shi, M Oviatt, J Doustar… - Frontiers in …, 2020‏ - frontiersin.org
The neurosensory retina emerges as a prominent site of Alzheimer's disease (AD)
pathology. As a CNS extension of the brain, the neuro retina is easily accessible for …

Deregulation of mitochondrial F1FO-ATP synthase via OSCP in Alzheimer's disease

SJ Beck, L Guo, A Phensy, J Tian, L Wang… - Nature …, 2016‏ - nature.com
Abstract F1FO-ATP synthase is critical for mitochondrial functions. The deregulation of this
enzyme results in dampened mitochondrial oxidative phosphorylation (OXPHOS) and …

Retinal vasculopathy in Alzheimer's disease

H Shi, Y Koronyo, A Rentsendorj, DT Fuchs… - Frontiers in …, 2021‏ - frontiersin.org
The retina has been increasingly investigated as a site of Alzheimer's disease (AD)
manifestation for over a decade. Early reports documented degeneration of retinal ganglion …

Pathology of the aging brain in domestic and laboratory animals, and animal models of human neurodegenerative diseases

SA Youssef, MT Capucchio, JE Rofina… - Veterinary …, 2016‏ - journals.sagepub.com
According to the WHO, the proportion of people over 60 years is increasing and expected to
reach 22% of total world's population in 2050. In parallel, recent animal demographic …

Synthesis and multitarget biological profiling of a novel family of rhein derivatives as disease-modifying anti-Alzheimer agents

E Viayna, I Sola, M Bartolini, A De Simone… - Journal of Medicinal …, 2014‏ - ACS Publications
We have synthesized a family of rhein–huprine hybrids to hit several key targets for
Alzheimer's disease. Biological screening performed in vitro and in Escherichia coli cells …

Alzheimer's disease mechanisms and emerging roads to novel therapeutics

C Sala Frigerio, B De Strooper - Annual review of neuroscience, 2016‏ - annualreviews.org
Ten years of remarkable progress in understanding the fundamental biochemistry of
Alzheimer's disease have been followed by ten years of remarkable and increasing clinical …